Monoclonal immunoglobulin-derived vaccine in patients with multiple myeloma - Phase II clinical study results;Protinádorová vakcína s využítím monoklonálního imunoglobulinu u nemocných s mnohočetným myelomem - Výsledky klinické studie fáze II

Klinicka Onkologie

Volumn 19, Issue 1, 2006, Pages 26-29

  Zahradova L ^a   Buchler T ^a   Smejkalova J ^a   Ocadlikova D ^a   Kovarova L ^a   Krejci M ^a   Adam, Z ^a   Penka, M ^a   Vorlicek J ^a   Hajek R ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Id protein; Immunotherapy; Multiple myeloma

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN;

ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DRUG CONJUGATION; DRUG EFFICACY; HUMAN; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MEDICAL DOCUMENTATION; MEMORY CELL; MULTIPLE MYELOMA; PHASE 2 CLINICAL TRIAL; RECURRENT DISEASE; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 33751037347     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kwak LW, Taub DD, Duffey PL et al. Transfer of myeloma id iotype-specific immunity from an actively immunized marrow donor. Lancet 1995; 345:1016-20.
2. Bergenbrant S, Yi Q, Osterborg A et al. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. Br J Haematol 1996; 92:840-6.
3. Osterborg A, Yi Q, Henriksson L et al. Idiotype immunizat ion combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell res ponses. Blood 1998; 91:2459-66.
4. Titzer S, Christensen O, Manzke O et al. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. Br J Haematol 2000; 108:805-16.
5. Büchler T, Hájek R. Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations. Med Oncol 2002; 19:213-8.
6. Büchler T, Musilová R, Kovářová L, Hájek R. Vakcíny v léč bě mnohočetného myelomu.. Klinická Onkologie 2002; 15 (Suppl):44-7.
7. Büchler T, Hanak L, Smejkalova J et al. Využití monokloná lního imunoglobulinu k přípravé protinádorové vakcíny u nemo cných s mnohočetným myelomem - první zkušenosti z klinické s tudie. Klinická onkologie 2004; 17:64-7.
8. Massaia M, Borrione P, Battaglio S et al. Idiotype vaccin ation in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood 1999; 94:673-83.
9. Reichardt VL, Okada CY, Liso A. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - a feasibility study. Blood 1999; 93:2411-9.
10. Liso A, Stockerl-Goldstein KE, Auffermann-Gretzinger S et al. Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2000; 6:621-7.
11. Hajek R, Zackova D, Buchler T et al. Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in EL-2 followed by IL-2, GM-CSF, and IFN-alpha administration. Med Oncol 2003; 20:69-76.
12. Musilová R, Táborská E, Bourková L et al. Příprava a pouź ití nádorového antigenu z patologického imunoglobulinu pro p acienty s mnohoćetny̌m myelomem. Transfuze a hematologie dnes 2002; 8:91-5.
13. Blade J, Samson D, Reece D et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Br J Haematol 1998. 102:1115-23.
14. Coscia M, Mariani S, Battaglio S et al. Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy. Leukemia 2004; 18:139-145.
15. Timmerman JM, Czerwinski DK, Davis AT et al. Idiotype-pulsed dendritic cells vaccination for B-cell lymfoma: clinical and immune response in 35 patients. Blood 2002. 99:1517-1526.
16. Cull G, Durrant L, Stainer C et al. Gereration of anti-idiotype immune responses following vaccination with idiotype- protein pulsed dendritic cells in myeloma. Br J Haematol 1999. 107:648-55.
17. Reichardt VL, Milazzo C, Brugger W et al. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells. Heamatologica 2003. 88:1139-49.
18. Hayashi T, Hideshima T, Akiyama M et al. Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes. Blood 2003. 102:1435-1442.